Analysts at Bernstein have raised their price target for Honeywell International to $243 per share, up from $230, as the conglomerate's planned spin-off of its advanced materials unit fuels expectations of sharper strategic focus and improved margins. The new target, issued on 17 July, represents a potential upside of roughly 8% from the stock's recent close and underscores growing confidence in the restructuring agenda.
Honeywell announced in May that it would separate its advanced materials business, which produces specialty chemicals and materials for industries such as semiconductors and aerospace, into a standalone company. The move is part of a broader trend among US industrial giants to simplify their corporate structures. Bernstein's analysts said the spin-off should allow Honeywell to concentrate on its core automation and aerospace operations, which typically command higher valuations.
The upgrade comes against a backdrop of cautious optimism in global equity markets. The S&P 500 edged up 0.3% on Friday, while the Dow Jones Industrial Average added 0.2%. Honeywell's shares gained 1.8% in pre-market trading following the Bernstein note, lifting the broader industrial sector. For UK investors, the news is relevant because Honeywell is a significant holding in many global equity funds and pension portfolios, particularly those with exposure to US industrials.
Bernstein's price target adjustment reflects a sum-of-the-parts valuation, which values the core business and the spin-off separately. The analysts argued that the separation could unlock between $5bn and $10bn in shareholder value through improved operational efficiency and strategic clarity. However, they cautioned that execution risks remain, including the timing of the spin-off and potential regulatory hurdles.
The spin-off is expected to be completed by early 2027, subject to customary conditions. For UK pension holders and retail investors with exposure to US equities, the development highlights the potential benefits of corporate restructuring, though analysts advise monitoring the execution closely. No investment advice is offered here.